Newly public CMO Recipharm has teamed up with Clinical Trial Consultants AB in a collaboration focused on producing materials for Phase I trials.
Under the new partnership – financial terms of which were not disclosed – Recipharm will combine its manufacturing capabilities with CTC’s early-phase clinical research offering based at Uppsala University Hospital in Sweden.
Martia Lundberg, general manager of Recipharm Pharmaceutical Development AB, said the idea is to “offer customers faster and more cost-efficient phase I studies. We can from now on take full responsibility for coordination of the work which might be valuable to small virtual companies.”
CTC, which was founded by former Berzelius Clinical Research Center AB and Quintiles AB staff in 2011, claims to have conducted 150 industry sponsored trials, around 10% of which were first-in-man studies.